Medical News

RSS

Risk posed by COVID-19 to newborn babies is low, research suggests

The first global analysis of existing scientific studies related to COVID-19 and newborn babies highlights that it is uncommon for babies aged up to four weeks old to become infected with the virus, with recorded cases experiencing only mild symptoms and making a full recovery.

30 May 2020

AstraZeneca implements Genestack’s flagship Omics Data Manager

Genestack Ltd. today announced that its flagship multi-omics data catalogue, curation and integrative search product, Omics Data Manager (ODM), has been licensed and implemented by AstraZeneca.

30 May 2020

GMU researcher receives $150,000 for COVID-19 networked meta-population modeling and analysis

Cameron Nowzari, Assistant Professor, Electrical and Computer Engineering, received $150,000 from the National Science Foundation for a project in which he and his collaborators are developing numerical methods and mathematical models to provide complementary support to the epidemiologists worldwide who are working to understand how COVID-19 spreads.

29 May 2020

Newer treatment approaches may reduce risk of therapy-related hematologic cancers

While breakthrough treatments have emerged for several cancers over the last two decades, driving striking improvements in survival and other clinical outcomes, too little is known about the risk of therapy-related hematologic cancers following targeted and immunotherapeutic approaches.

29 May 2020

First-ever oncology hospital-at-home program improves patient outcomes, reduces hospitalizations

Researchers at Huntsman Cancer Institute at the University of Utah (U of U) presented the first outcomes evaluation of an adult oncology hospital-at-home program today at the 2020 American Society of Clinical Oncology annual meeting.

29 May 2020

Clinical trial shows anti-tumor responses in metastatic castration-resistant prostate cancer patients

The preliminary results of a Phase I clinical trial conducted by researchers at the Yale Cancer Center have shown that ARV-110, an androgen receptor PROTAC protein degrader, demonstrates clinical evidence of anti-tumor responses in patients with metastatic castration-resistant prostate cancer (mCRPC) who have failed prior therapy.

29 May 2020

C-DOCTOR receives $30-million grant from NIDCR for tissue and organ regeneration research

The initiative aims to propel USC forward as the epicenter of tissue and organ regeneration research.

29 May 2020

Monoclonal antibody therapy achieves modest reduction in recurrence for patients with HER2-positive DCIS

The addition of the monoclonal antibody therapy Trastuzumab to radiotherapy did not reach the protocol objective of a 36% reduction in the ipsilateral breast tumor recurrence rate for women with HER2-positive ductal carcinoma in situ (DCIS) on the NRG Oncology clinical trial NSABP B-43.

29 May 2020

High-throughput analysis of blood plasma could help identify biomarkers for ALS

High-throughput analysis of blood plasma could aid in identification of diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis (ALS), according to research from North Carolina State University.

29 May 2020

Study examines COVID-19-related stress and coping strategies in people with chronic conditions

Active coping, denial, emotional support, humor and religion are among the coping strategies that help people with chronic conditions and disabilities deal with stress caused by the COVID-19 pandemic, according to a recently published study written by researchers at The University of Texas at El Paso.

29 May 2020

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

The adoptive T-cell therapy ADP-A2M4, which is engineered to express a T-cell receptor (TCR) directed against the MAGE-A4 cancer antigen, achieved responses in patients with multiple solid tumor types, including synovial sarcoma, head and neck cancer and lung cancer, according to results from a Phase I clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.

29 May 2020

Using functional MRI to demonstrate neural suppression in autism

According to the National Autism Association, people with autism spectrum disorder (ASD) may experience sensory hypersensitivity.

29 May 2020

UMSOM scientists develop experimental rapid diagnostic test for COVID-19

Scientists from the University of Maryland School of Medicine (UMSOM) developed an experimental diagnostic test for COVID-19 that can visually detect the presence of the virus in 10 minutes.

29 May 2020

Targeted therapy tepotinib shows durable response in NSCLC patients with METex14 skipping mutation

Patients with advanced non-small cell lung cancer (NSCLC) and the MET exon 14 (METex14) skipping mutation had a 46.5% objective response rate to the targeted therapy drug tepotinib, as shown in a study published today in the New England Journal of Medicine and presented at the 2020 American Society of Clinical Oncology Annual Meeting ASCO20 Virtual Meeting (Abstract 9556 - Poster 322) by researchers from The University of Texas MD Anderson Cancer Center.

29 May 2020

Targeted therapy pralsetinib shows high response rates in patients with RET fusion-positive cancers

The targeted therapy pralsetinib appears to have high response rates and durable activity in patients with a broad variety of tumors harboring RET gene fusions, according to results from the international Phase I/II ARROW trial, led by researchers at The University of Texas MD Anderson Cancer Center.

29 May 2020

Addition of monoclonal antibody to trimodality therapy offers no benefit in HER2 over expressing esophageal cancer

Results of the NRG Oncology clinical trial RTOG 1010 indicated that the addition of the monoclonal antibody trastuzumab to neoadjuvant trimodality treatment did not improve disease-free survival outcomes for patient with HER2 overexpressing local and locally advanced esophageal adenocarcinoma.

29 May 2020

New tool predicts COVID-19 peaks around the world

As of late May, COVID-19 has killed more than 325,000 people around the world. Even though the worst seems to be over for countries like China and South Korea, public health experts warn that cases and fatalities will continue to surge in many parts of the world.

29 May 2020

Paid sick leave mandates may be helping to slow the spread of COVID-19

Paid sick leave (PSL) mandates like those found in the federal government's Families First Coronavirus Response Act may be helping to slow the spread of COVID-19, according to a new study by health economists at Georgia State and Tulane universities.

29 May 2020

UTHSC researcher awarded NIH grant to study age-related multimorbidity

A UTHSC researcher has been awarded an R15 grant from the National Institutes of Health for her work to identify and understand trends in age-related multimorbidity.

29 May 2020

Study finds nitrous oxide use during labor to be safe with rare side effects

Researchers at the University of Colorado College of Nursing and the School of Medicine Department of Anesthesiology at the Anschutz Medical Campus found that the use of nitrous oxide as a pain relief option for individuals in labor is safe for newborn children and laboring individual, and converting to a different form of pain relief such as an epidural or opioid is influenced by a woman's prior birth history and other factors.

29 May 2020

Medical News

Risk posed by COVID-19 to newborn babies is low, research suggests

AstraZeneca implements Genestack’s flagship Omics Data Manager

GMU researcher receives $150,000 for COVID-19 networked meta-population modeling and analysis

Newer treatment approaches may reduce risk of therapy-related hematologic cancers

First-ever oncology hospital-at-home program improves patient outcomes, reduces hospitalizations

Clinical trial shows anti-tumor responses in metastatic castration-resistant prostate cancer patients

C-DOCTOR receives $30-million grant from NIDCR for tissue and organ regeneration research

Monoclonal antibody therapy achieves modest reduction in recurrence for patients with HER2-positive DCIS

High-throughput analysis of blood plasma could help identify biomarkers for ALS

Study examines COVID-19-related stress and coping strategies in people with chronic conditions

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

Using functional MRI to demonstrate neural suppression in autism

UMSOM scientists develop experimental rapid diagnostic test for COVID-19

Targeted therapy tepotinib shows durable response in NSCLC patients with METex14 skipping mutation

Targeted therapy pralsetinib shows high response rates in patients with RET fusion-positive cancers

Addition of monoclonal antibody to trimodality therapy offers no benefit in HER2 over expressing esophageal cancer

New tool predicts COVID-19 peaks around the world

Paid sick leave mandates may be helping to slow the spread of COVID-19

UTHSC researcher awarded NIH grant to study age-related multimorbidity

Study finds nitrous oxide use during labor to be safe with rare side effects

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News